Cited by 193Glioma Diagnosis and TreatmentElectromagnetic Fields and Biological EffectsMicrobial Inactivation Methods

Tumor treating fields: A new frontier in cancer therapy

Davies, Angela M., Weinberg, Uri, Palti, Yoram·2013·Annals of the New York Academy of Sciences

Abstract

Tumor treating fields (TTFields) is a noninvasive, regional antimitotic treatment modality that has been approved for the treatment of recurrent glioblastoma by the U.S. FDA and has a CE mark in Europe. TTFields therapy delivers low-intensity (1-3 V/cm), intermediate-frequency (100-300 kHz), alternating electric fields to the tumor using transducer arrays placed on the skin around the region of the body containing the tumor. TTFields therapy affects metaphase, by disrupting mitotic spindle formation, and anaphase, by dielectrophoretic dislocation of intracellular constituents, resulting in apoptosis. TTFields therapy is frequency tuned to specific cancer cell types. The antimitotic effect of TTFields therapy has been demonstrated in multiple cell lines when the appropriate frequency was utilized. A phase III trial of TTFields monotherapy compared to active chemotherapy in recurrent glioblastoma patients established that TTFields therapy is associated with minimal toxicity, better quality of life, and comparable efficacy to chemotherapy. Ongoing and future trials will evaluate TTFields in newly diagnosed glioblastoma, solid tumor brain metastases, nonsmall cell lung cancer, and ovarian and pancreatic cancers.

Integrity signals

Registry

Crossref · 10.1111/nyas.12112

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Low-intensity (1-3 V/cm), intermediate frequency (100-300 kHz) electric fields have a profoundly inhibitory effect on the growth rate of various mammalian tumor cell lines.

    “Kirson et al. [2] reported the discovery that low-intensity (1–3 V/cm), intermediate frequency (100–300 kHz) electric fields have a profoundly inhibitory effect on the growth rate of various mammalian tumor cell lines [2,3,4].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Davies, A. M., Weinberg, U., & Palti, Y.
Affiliations
Novocure (United States) (US)
Corresponding author
Davies, Angela M.
Venue
Annals of the New York Academy of Sciences
Publisher
Wiley
Published
2013-05-09
Volume
1291
Issue
1
Pages
86-95
ISSN
  • 0077-8923 (ISSN-L)
  • 1749-6632
OpenAlex
W1875003163
Cited by
193
References
34
Citations by year
2026: 7 · 2025: 12 · 2024: 11 · 2023: 29 · 2022: 30 · 2021: 17 · 2020: 20 · 2019: 12 · 2018: 13 · 2017: 14 · 2016: 9 · 2015: 10 · 2014: 9
FWCI
1.28
Type
journal article
Language
en
Open access
closed
Locations
  • Annals of the New York Academy of Sciences (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Genetics › Glioma Diagnosis and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biophysics › Electromagnetic Fields and Biological Effects
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Microbial Inactivation Methods
Keywords
tumor treating fields, glioblastoma, recurrent glioblastoma, antimitotic therapy, AC electric field, mitotic spindle disruption, dielectrophoresis, apoptosis, transducer array, frequency tuning, noninvasive cancer therapy, brain metastases, non-small cell lung cancer, ovarian cancer, pancreatic cancer
MeSH terms
Animals, Clinical Trials as Topic, Electromagnetic Fields, Electric Stimulation Therapy, Humans, Neoplasms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review